Switch theme
Sign up to access all valuation multiples
BIO-UV Group is a manufacturer of ultraviolet (UV) water treatment equipment in France. It designs, manufactures and markets systems and concepts of disinfection by ultraviolet light (UV-C) adapted to the number of applications. The company offers products for disinfecting swimming pools and private and collective hot tubs, treating wastewater, producing drinking water, treating bilge water from ships and water from aquariums.
2000
61
LTM Revenue $43.0M
LTM EBITDA $5.8M
$48.8M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
BIO-UV has a last 12-month revenue of $43.0M and a last 12-month EBITDA of $5.8M.
In the most recent fiscal year, BIO-UV achieved revenue of $46.3M and an EBITDA of $5.8M.
BIO-UV expects next 12-month revenue of XXX and NTM EBITDA of XXX
See BIO-UV valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $55.1M | $46.3M | XXX | XXX | XXX |
| Gross Profit | $12.7M | $18.0M | XXX | XXX | XXX |
| Gross Margin | 23% | 39% | XXX | XXX | XXX |
| EBITDA | $7.4M | $5.8M | XXX | XXX | XXX |
| EBITDA Margin | 13% | 12% | XXX | XXX | XXX |
| Net Profit | $0.7M | $2.6M | XXX | XXX | XXX |
| Net Margin | 1% | 6% | XXX | XXX | XXX |
| Net Debt | n/a | $2.9M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 18, 2025, BIO-UV's stock price is EUR 2 (or $2).
BIO-UV has current market cap of EUR 23.2M (or $24.9M), and EV of EUR 45.4M (or $48.8M).
See BIO-UV trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $48.8M | $24.9M | XXX | XXX | XXX | XXX | $0.03 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 18, 2025, BIO-UV has market cap of $24.9M and EV of $48.8M.
BIO-UV's trades at 1.1x LTM EV/Revenue multiple, and 8.4x LTM EBITDA.
Analysts estimate BIO-UV's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for BIO-UV and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $48.8M | XXX | XXX | XXX |
| EV/Revenue | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | 8.4x | XXX | XXX | XXX |
| P/E | 185.9x | XXX | XXX | XXX |
| P/E/Growth | 0.8x | XXX | XXX | XXX |
| EV/FCF | 10.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpBIO-UV's NTM/LTM revenue growth is 4%
BIO-UV's revenue per employee for the last fiscal year averaged $0.8M, while opex per employee averaged $0.4M for the same period.
Over next 12 months, BIO-UV's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate BIO-UV's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for BIO-UV and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -16% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -22% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 16% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.8M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.4M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 54% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| XXX | XXX | XXX | XXX | XXX | XXX | |
| Aalberts | XXX | XXX | XXX | XXX | XXX | XXX |
| ABB India | XXX | XXX | XXX | XXX | XXX | XXX |
| Cummins India | XXX | XXX | XXX | XXX | XXX | XXX |
| Escorts Kubota | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
BIO-UV acquired XXX companies to date.
Last acquisition by BIO-UV was XXXXXXXX, XXXXX XXXXX XXXXXX . BIO-UV acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was BIO-UV founded? | BIO-UV was founded in 2000. |
| Where is BIO-UV headquartered? | BIO-UV is headquartered in France. |
| How many employees does BIO-UV have? | As of today, BIO-UV has 61 employees. |
| Is BIO-UV publicy listed? | Yes, BIO-UV is a public company listed on PAR. |
| What is the stock symbol of BIO-UV? | BIO-UV trades under ALTUV ticker. |
| When did BIO-UV go public? | BIO-UV went public in 2018. |
| Who are competitors of BIO-UV? | Similar companies to BIO-UV include e.g. , Aalberts, ABB India, Cummins India. |
| What is the current market cap of BIO-UV? | BIO-UV's current market cap is $24.9M |
| What is the current revenue of BIO-UV? | BIO-UV's last 12-month revenue is $43.0M. |
| What is the current EBITDA of BIO-UV? | BIO-UV's last 12-month EBITDA is $5.8M. |
| What is the current EV/Revenue multiple of BIO-UV? | Current revenue multiple of BIO-UV is 1.1x. |
| What is the current EV/EBITDA multiple of BIO-UV? | Current EBITDA multiple of BIO-UV is 8.4x. |
| What is the current revenue growth of BIO-UV? | BIO-UV revenue growth between 2023 and 2024 was -16%. |
| Is BIO-UV profitable? | Yes, BIO-UV is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
